A citation-based method for searching scientific literature

Iara Pérez-Taboada, Samuel Alberquilla, Eduardo D Martín, Rishi Anand, Stefania Vietti-Michelina, Nchimunya N Tebeka, James Cantley, Stephanie J Cragg, Rosario Moratalla, Mario Vallejo. Mov Disord 2020
Times Cited: 20







List of co-cited articles
145 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Diabetes mellitus and Parkinson disease.
Gennaro Pagano, Sotirios Polychronis, Heather Wilson, Beniamino Giordano, Nicola Ferrara, Flavia Niccolini, Marios Politis. Neurology 2018
99
25

Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
Chien-Tai Hong, Kai-Yun Chen, Weu Wang, Jing-Yuan Chiu, Dean Wu, Tsu-Yi Chao, Chaur-Jong Hu, Kai-Yin David Chau, Oluwaseun Adebayo Bamodu. Cells 2020
38
20

Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
Ivan Martinez-Valbuena, Irene Amat-Villegas, Rafael Valenti-Azcarate, Maria Del Mar Carmona-Abellan, Irene Marcilla, Maria-Teresa Tuñon, Maria-Rosario Luquin. Acta Neuropathol 2018
36
20


Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences.
Domenico Sergi, Justine Renaud, Nicola Simola, Maria-Grazia Martinoli. Front Aging Neurosci 2019
36
20

Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis.
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, Catherine Klersy, Erica Cassani, Riccardo Caccialanza, Gianni Pezzoli. Diabetes Care 2011
139
15

Clinical features of Parkinson disease when onset of diabetes came first: A case-control study.
E Cereda, M Barichella, E Cassani, R Caccialanza, G Pezzoli. Neurology 2012
93
15

Association between Parkinson's disease and diabetes: Data from NEDICES study.
E De Pablo-Fernandez, F Sierra-Hidalgo, J Benito-León, F Bermejo-Pareja. Acta Neurol Scand 2017
38
15


Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View.
Alice Biosa, Tiago F Outeiro, Luigi Bubacco, Marco Bisaglia. Mol Neurobiol 2018
41
15

Exendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned rat.
Amjad Abuirmeileh, Alexander Harkavyi, Nazir Rampersaud, Rebecca Lever, John A Tadross, Stephen R Bloom, Peter S Whitton. J Pharm Pharmacol 2012
24
15

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson,[...]. Lancet 2017
361
15

A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.
Ziyue Yuan, Dongfang Li, Peng Feng, Guofang Xue, Chenhui Ji, Guanglai Li, Christian Hölscher. Eur J Pharmacol 2017
58
15

Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease.
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Joshua Kahan, Peter Ell, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Parkinsons Dis 2014
172
15

A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.
Chenhui Ji, Guo-Fang Xue, Cao Lijun, Peng Feng, Dongfang Li, Lin Li, Guanglai Li, Christian Hölscher. Brain Res 2016
65
15


GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
Yazhou Li, TracyAnn Perry, Mark S Kindy, Brandon K Harvey, David Tweedie, Harold W Holloway, Kathleen Powers, Hui Shen, Josephine M Egan, Kumar Sambamurti,[...]. Proc Natl Acad Sci U S A 2009
412
15

Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.
Aree Witoelar, Iris E Jansen, Yunpeng Wang, Rahul S Desikan, J Raphael Gibbs, Cornelis Blauwendraat, Wesley K Thompson, Dena G Hernandez, Srdjan Djurovic, Andrew J Schork,[...]. JAMA Neurol 2017
154
15

Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies.
Hugo Vicente Miranda, Éva M Szego, Luís M A Oliveira, Carlo Breda, Ekrem Darendelioglu, Rita M de Oliveira, Diana G Ferreira, Marcos A Gomes, Ruth Rott, Márcia Oliveira,[...]. Brain 2017
106
15

Post hoc analysis of the Exenatide-PD trial-Factors that predict response.
Dilan Athauda, Kate Maclagan, Natalia Budnik, Luca Zampedri, Steve Hibbert, Iciar Aviles-Olmos, Kashfia Chowdhury, Simon S Skene, Patricia Limousin, Thomas Foltynie. Eur J Neurosci 2019
32
15

Type 2 diabetes and the risk of Parkinson's disease.
Gang Hu, Pekka Jousilahti, Siamak Bidel, Riitta Antikainen, Jaakko Tuomilehto. Diabetes Care 2007
292
15

The Relevance of Insulin Action in the Dopaminergic System.
Francesca Fiory, Giuseppe Perruolo, Ilaria Cimmino, Serena Cabaro, Francesca Chiara Pignalosa, Claudia Miele, Francesco Beguinot, Pietro Formisano, Francesco Oriente. Front Neurosci 2019
37
15

IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
K Ogurtsova, J D da Rocha Fernandes, Y Huang, U Linnenkamp, L Guariguata, N H Cho, D Cavan, J E Shaw, L E Makaroff. Diabetes Res Clin Pract 2017
15


Cognitive Dysfunction in Type 1 Diabetes Mellitus.
Anna Shalimova, Beata Graff, Dariusz Gąsecki, Jacek Wolf, Agnieszka Sabisz, Edyta Szurowska, Krzysztof Jodzio, Krzysztof Narkiewicz. J Clin Endocrinol Metab 2019
42
15

Insulin resistance in brain alters dopamine turnover and causes behavioral disorders.
Andre Kleinridders, Weikang Cai, Laura Cappellucci, Armen Ghazarian, William R Collins, Sara G Vienberg, Emmanuel N Pothos, C Ronald Kahn. Proc Natl Acad Sci U S A 2015
217
15

Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway.
Justine Renaud, Valentina Bassareo, Jimmy Beaulieu, Annalisa Pinna, Michele Schlich, Carole Lavoie, Daniela Murtas, Nicola Simola, Maria-Grazia Martinoli. Neurobiol Aging 2018
23
15

Dementia is associated with insulin resistance in patients with Parkinson's disease.
Domenico Bosco, Massimiliano Plastino, Dario Cristiano, Carmela Colica, Caterina Ermio, Matteo De Bartolo, Pasquale Mungari, Giulia Fonte, Domenico Consoli, Arturo Consoli,[...]. J Neurol Sci 2012
85
10

Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
A Vella, P Shah, A S Reed, A S Adkins, R Basu, R A Rizza. Diabetologia 2002
81
10

PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson's Disease.
Seong-Jin Yu, Shuchun Chen, Yung-Yung Yang, Elliot J Glotfelty, Jin Jung, Hee Kyung Kim, Ho-Il Choi, Doo-Sup Choi, Barry J Hoffer, Nigel H Greig,[...]. Front Neurosci 2020
12
16


Glitazone use associated with reduced risk of Parkinson's disease.
Brage Brakedal, Irene Flønes, Simone F Reiter, Øivind Torkildsen, Christian Dölle, Jörg Assmus, Kristoffer Haugarvoll, Charalampos Tzoulis. Mov Disord 2017
67
10

Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells.
Antonella Maffei, Ann Marie Segal, Juan Carlos Alvarez-Perez, Adolfo Garcia-Ocaña, Paul E Harris. Mol Endocrinol 2015
29
10

Neuroprotective effect of glucagon-like peptide-1 receptor agonist is independent of glycaemia normalization in type two diabetic rats.
Irina Filchenko, Anna Simanenkova, Svetlana Chefu, Maria Kolpakova, Timur Vlasov. Diab Vasc Dis Res 2018
16
12

Long-term liraglutide ameliorates nigrostriatal impairment via regulating AMPK/PGC-1a signaling in diabetic mice.
Delin Ma, Xiaming Liu, Juanhong Liu, Mengni Li, Li Chen, Ming Gao, Weijie Xu, Yan Yang. Brain Res 2019
12
16

Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.
Istvan Horvath, Pernilla Wittung-Stafshede. Proc Natl Acad Sci U S A 2016
85
10

A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.
Dong Seok Kim, Ho-Il Choi, Yun Wang, Yu Luo, Barry J Hoffer, Nigel H Greig. Cell Transplant 2017
76
10


Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.
Caterina Palleria, Antonio Leo, Francesco Andreozzi, Rita Citraro, Michelangelo Iannone, Rosangela Spiga, Giorgio Sesti, Andrew Constanti, Giovambattista De Sarro, Franco Arturi,[...]. Behav Brain Res 2017
56
10

Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.
Ting Wang, Feilan Yuan, Zhenze Chen, Shuzhen Zhu, Zihan Chang, Wanlin Yang, Bin Deng, Rongfang Que, Peihua Cao, Yinxia Chao,[...]. Aging (Albany NY) 2020
23
10

Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling.
Shanshan Gao, Chunli Duan, Ge Gao, Xiaoming Wang, Hui Yang. Int J Biochem Cell Biol 2015
53
10

Diabetes and risk of Parkinson's disease.
Qun Xu, Yikyung Park, Xuemei Huang, Albert Hollenbeck, Aaron Blair, Arthur Schatzkin, Honglei Chen. Diabetes Care 2011
169
10

GLP-1 receptor agonists for Parkinson's disease.
Caroline A Mulvaney, Gonçalo S Duarte, Joel Handley, David Jw Evans, Suresh Menon, Richard Wyse, Hedley Ca Emsley. Cochrane Database Syst Rev 2020
19
10

Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
Nikita Katila, Sunil Bhurtel, Sina Shadfar, Sunil Srivastav, Sabita Neupane, Uttam Ojha, Gil-Saeng Jeong, Dong-Young Choi. Neuropharmacology 2017
87
10


Release of insulin produced by the choroid plexis is regulated by serotonergic signaling.
Caio Henrique Mazucanti, Qing-Rong Liu, Doyle Lang, Nicholas Huang, Jennifer F O'Connell, Simonetta Camandola, Josephine M Egan. JCI Insight 2019
29
10


Metformin regulates astrocyte reactivity in Parkinson's disease and normal aging.
Young-Kyoung Ryu, Jun Go, Hye-Yeon Park, Young-Keun Choi, Yun Jeong Seo, Jung Hyeon Choi, Myungchull Rhee, Tae Geol Lee, Chul-Ho Lee, Kyoung-Shim Kim. Neuropharmacology 2020
25
10

What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson's Disease: A Post Hoc Analysis.
Dilan Athauda, Kate Maclagan, Natalia Budnik, Luca Zampedri, Steve Hibbert, Simon S Skene, Kashfia Chowdhury, Iciar Aviles-Olmos, Patricia Limousin, Thomas Foltynie. J Parkinsons Dis 2018
33
10

Amylin brain circuitry.
Lavinia Boccia, Salome Gamakharia, Bernd Coester, Lynda Whiting, Thomas A Lutz, Christelle Le Foll. Peptides 2020
17
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.